指动物、人的原代细胞受到病毒感染、外源基因插入、辐射或药物作用后,
细胞分裂能力从有限的倍增次数转变为可以无限体外扩增的能力。该项技术的出 现极大的丰富了人们对于珍贵的、不能体外大量扩增细胞的来源。
|
||||||||||||||||||
[发表评论] [本类其他服务] [本类其他服务商] |
![]() |
服务商: 上海中乔新舟生物科技有限公司 | 查看该公司所有服务 >> |
指动物、人的原代细胞受到病毒感染、外源基因插入、辐射或药物作用后,
细胞分裂能力从有限的倍增次数转变为可以无限体外扩增的能力。该项技术的出
现极大的丰富了人们对于珍贵的、不能体外大量扩增细胞的来源。
三个方案可供选择:
部分产品列表如下:
1 Conditionally Immortalized Human Bone Marrow-Derived Mesenchymal Stem Cells
2 Conditionally Immortalized Human Bone Marrow-Derived Mesenchymal Stem Cells
3 Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells
4 Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells
5 Conditionally Immortalized Human Umbilical Cord-Derived Mesenchymal Stem Cells
6 Conditionally Immortalized Human Umbilical Cord-Derived Mesenchymal Stem Cells
7 Conditionally Immortalized Human Retinal Pigment Epithelial Cells
8 Conditionally Immortalized Human Retinal Pigment Epithelial Cells
9 Conditionally Immortalized Human Neuron Cells
10 Conditionally Immortalized Human Neuron Cells
11 Conditionally Immortalized Human Liver Stellate Cells
12 Conditionally Immortalized Human Liver Stellate Cells
13 Conditionally Immortalized Rat Cardiac Microvascular Endothelial Cells
14 Conditionally Immortalized Rat Cardiac Microvascular Endothelial Cells